This method not only provides key technical support for the subsequent quantitative analysis of VGLL3 in large-scale population samples but also expands the application potential of avian antibodies in the detection of high-risk proteins (such as TDP-43 and FUS) in neurodegenerative diseases and tumors [32,33,34]. The gene discussed is VGLL3; the disease is neurodegenerative disease.